In ESCC, we found that PDIA3 decreased gradually with the progress of stage and related to favorable prognosis, which was in accord with the findings in gastric cancer [49], but contrary to those in hepatocellular carcinoma [50]. The gene discussed is PDIA3; the disease is gastric cancer.